Procurement Summary
Country: USA
Summary: Dow Lupus, Transformative Vision Development Award
Deadline: 24 Aug 2026
Posting Date: 06 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140728152
Document Ref. No.: HT942526LRPTVDA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Summary: This Funding Mechanism Supports Planning And Development Activities And Pilot Studies That Will Generate Preliminary Data And Demonstrate Feasibility For Achieving The Aims Of A Future Interventional Study. Successful Studies May Be Submitted To A Future Lupus Research Program (Lrp) Transformative Vision Award (Tva), Or Equivalent, For Funding Consideration (See Funding Opportunity Number Ht942526Lrptva For Additional Information). Research Must Address At Least One Of The Fiscal Year 2026 (Fy26) Lrp Transformative Vision Development Award (Tvda) Focus Areas. This Funding Mechanism Allows For Phase 0/1 Clinical Trials, If Appropriate. The Mechanism Does Not Allow For Phase 2/3 Clinical Trials Or Animal Studies.Distinctive Features:• Preliminary Data Are Permitted But Not Required.• Applications Must Include At Least One Lupus Consumer Advocate As A Member Of The Research Team.• An Individual May Be Named As Principal Investigator (Pi) On Only One Application Per Lrp Award Mechanism (Idea Award, Impact Award, Tvda, Tva), For A Maximum Of Four Applications To The Fy26 Lrp.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Namedescriptionlast Updatedfy 26 Lrp Tvda Program Announcementmay 5, 2026 02:53 Pm Utclink To Additional Information--Closing: August 24, 2026
Posted Date: 2026-05-05 00:00:00
Funding instrument type: Grant
Documents
Tender Notice